3-Bromoquinoline-8-carboxamide

Catalog No.: 
ACQCHS425
CAS No.: 
1315368-19-4
Molecular Formula: 
C10H7BrN2O
Molecular Weight: 
251.08
3-Bromoquinoline-8-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$173.00InquiryInquiry
1g95%$500.00InquiryInquiry
5g95%$2450.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromoquinoline-8-carboxamide
IUPAC Name3-bromoquinoline-8-carboxamide
MDL No.MFCD19382316
Molecular FormulaC10H7BrN2O
Molecular Weight251.08
SMILESO=C(C1=C2N=CC(Br)=CC2=CC=C1)N
InChI KeyPEJYIMPKMBACHX-UHFFFAOYSA-N
Synonym8-Quinolinecarboxamide, 3-bromo-;3-Bromoquinoline-8-carboxamide
CAS No.1315368-19-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQCHS425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUQGH812 route compound structure diagram
    ACUQGH8121315366-78-9In Stock
  2. Then
  3. ACQCHS425 route product structure diagram
    ACQCHS4251315368-19-4
Inquiry

2. ACQCHS425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACUQGH812 route compound structure diagram
    ACUQGH8121315366-78-9In Stock
  4. Then
  5. ACQCHS425 route product structure diagram
    ACQCHS4251315368-19-4
Inquiry

3. ACQCHS425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACODXJ523 route compound structure diagram
    ACODXJ5231823896-96-3In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACQCHS425 route product structure diagram
    ACQCHS4251315368-19-4
Inquiry

Comments (0)